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MaOBJECTIVES This study sought to understand the physiological basis of baseline distal-to-aortic pressure ratio (Pd/Pa)
and fractional ﬂow reserve (FFR) agreement and discordance, using coronary ﬂow reserve (CFR), stenosis resistance, and
microcirculatory resistance measurements, and form there, to investigate the potential value of combining Pd/Pa with
FFR in the diagnostic rationale.
BACKGROUND Pd/Pa is always available before FFR assessment, and emerging data supports the notion that baseline
indices can determine the ischemic potential of coronary stenosis in selected subsets.
METHODS A total of 467 stenosed vessels from 363 patients were investigated with pressure and ﬂow sensors during
baseline and hyperemia: 168 vessels (135 patients) with thermodilution-derived ﬂow, and 299 vessels (228 patients) with
Doppler-derived ﬂow.
RESULTS Pd/Pa correlated more strongly with CFR than FFR (r difference ¼ 0.129; p for r comparison <0.001).
Although Pd/Pa and FFR were closely correlated (r ¼ 0.798; 95% conﬁdence interval: 0.767 to 0.828), categorical
discordance was observed in 19.3% of total vessels. Such discordance was associated with the patients’ clinical proﬁle
and was characterized by contrastive changes in stenosis resistance, microcirculatory resistance, and the underlying CFR.
Notably, all stenosis with Pd/Pa#0.83 (n ¼ 74, 15.8%) progressed to FFR#0.80, and although no Pd/Pa cutoff was able
to exclude the development of FFR #0.80 in the high end of values, only 15 (10.1%) vessels with Pd/Pa $0.96
(n ¼ 149, 31.9%) developed FFR #0.80, from which none had deﬁnite ischemia, as deﬁned by CFR #1.74.
CONCLUSIONS Combining baseline Pd/Pa with FFR seems to provide a more comprehensive physiological examination
of stenosed coronary arteries and a closer pressure-based appraisal of the ﬂow reserve of the downstream
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ABBR EV I A T I ON S
AND ACRONYMS
A-vessels = both baseline
distal-to-aortic pressure ratio
and fractional ﬂow reserve are
abnormal
B-vessels = only fractional
ﬂow reserve is abnormal
CFR = coronary ﬂow reserve
CI = conﬁdence interval(s)
C-vessels = only baseline
distal-to-aortic pressure ratio is
abnormal
D-vessels = both baseline
distal-to-aortic pressure ratio
and fractional ﬂow reserve are
normal
FFR = fractional ﬂow reserve
MR = microcirculatory
resistance
Pd/Pa = baseline distal-to-
aortic pressure ratio
Q1-3 = quartile 1, quartile 3
SR = stenosis resistance
Thermo = thermodilution
Tmn = thermodilution transit
time
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1682F ractional ﬂow reserve (FFR) hasbecome the standard method to assesscoronary stenosis severity in the cath-
eterization laboratory following the demon-
stration that physiological rather than
anatomical selection of stenosis candidates
for revascularization results in better patient
outcomes (1). This positive evidence has
stimulated the interest in FFR and other
physiology indices, and a desire for simpliﬁ-
cation has speciﬁcally boosted the attention
to nonhyperemic indices (2). The base-
line distal-to-aortic pressure ratio (Pd/Pa) is
always available before FFR assessment,
and several studies have shown that a Pd/Pa
value close to 0.90 provides the best classiﬁ-
cation match with the clinically adopted 0.80
FFR cutoff, which is approximately 80%
(3,4). This implies that most stenoses that
will develop FFR #0.80 have already rela-
tively low Pd/Pa values, and conversely,
that most stenoses that will develop a ﬁnal
FFR >0.80 arise from high values of Pd/Pa.
This also denotes, however, that in approxi-
mately 20% of the cases, Pd/Pa will not
match dichotomously with FFR, because insome vessels an FFR value #0.80 will emerge from
a near-normal Pd/Pa ratio, whereas in others, an
FFR >0.80 will be preceded by an already fairly low
Pd/Pa. Although this disagreement is used to stress
the importance of standardizing measurements at
hyperemia, its physiological basis is poorly described.TABLE 1 Physiology Indices Used in Study
CFR ¼ hyperemic ﬂow/ baseline ﬂow Thermodilution-derived ﬂow:
Pd/Pa ¼ mean Pd/mean Pa (baseline) 1/mean transit time, s
FFR ¼ mean Pd/mean Pa (hyperemia) Doppler-derived ﬂow:
SR ¼ (mean Pa - mean Pd)/ﬂow* Average peak ﬂow
MR ¼ mean Pd/ﬂow* velocity, cm/s
*SR and MR were calculated at baseline and hyperemia.
CFR ¼ coronary ﬂow reserve; FFR ¼ fractional ﬂow reserve; Pa ¼ aortic pres-
sure; Pd ¼ distal coronary pressure; MR ¼ microcirculatory resistance;
SR ¼ stenosis resistance.
SEE PAGE 1692In this study, we investigated stenosed coronary
arteries with combined intracoronary pressure and
ﬂow sensors because this allows selective interroga-
tion of the epicardial stenosis resistance (SR), micro-
circulatory resistance (MR), and the coronary ﬂow
reserve (CFR) of the downstream vascular bed (5). We
aimed ﬁrstly to explore the physiological basis of the
agreement and discordance between baseline Pd/Pa
and FFR and secondly to test whether adding baseline
Pd/Pa to the diagnostic rationale conveys important
information able to expand the physiological lone-
FFR assessment.
METHODS
STUDY POPULATION. Patients with a clinical indica-
tion for FFR interrogation of $1 intermediate coronary
stenosis (40% to 70% diameter stenosis), investigated
at Hospital Clinico San Carlos, Madrid, Spain, and
the Academic Medical Centre, Amsterdam, theNetherlands, were prospectively studied. Patients
with the following were excluded: myocardial
infarction within 5 days; contraindications to aden-
osine; left ventricle ejection fraction <30%; left main
disease; or signiﬁcant valvular pathology; as well
as vessels supplying previously known infarcted
territories, with serial stenoses, marked diffuse nar-
rowings, or with patent surgical grafts. All patients
gave informed consent and approval from the insti-
tutional review boards was obtained according to
local regulations.
CARDIAC CATHETERIZATION AND HEMODYNAMIC
MEASUREMENTS. Cardiac catheterization was per-
formed according to standard practice. Angiographic
views were obtained following intracoronary nitrates
(0.2 mg) in a manner suitable for quantitative coro-
nary angiography analysis. After diagnostic angiog-
raphy, sensor-equipped guidewires were used to
measure intracoronary pressure and ﬂow according to
described methodologies (6,7). Brieﬂy, in Hospital
Clinico San Carlos, coronary ﬂow was assessed with
the coronary thermodilution method (8). Resting and
hyperemic thermodilution curves were obtained in
triplicate, and CFR calculated as the ratio of average
baseline mean thermodilution transit time (Tmn) to
hyperemic Tmn. The inverse of baseline Tmn and
hyperemic Tmn was computed and labeled as base-
line and hyperemic ﬂow, respectively (8). In the Ac-
ademic Medical Centre, coronary ﬂow velocity was
assessed using Doppler sensors as described else-
where (7). Baseline and hyperemic average peak ﬂow
velocities were recorded, and coronary ﬂow velocity
reserve was calculated as the ratio of hyperemic to
baseline ﬂow velocity. Because coronary ﬂow velocity
reserve and thermodilution-derived CFR are unitless
and very strongly correlated (9), the term CFR was
used and datasets merged. Indices of ﬂow, SR, and
MR were calculated as depicted in Table 1. Hyperemia
was induced with adenosine, either by intravenous
infusion through a central vein (140 mg/kg/min) at
Hospital Clinico San Carlos, or intracoronary boluses
(20 to 40 mg) at the Academic Medical Centre. Finally,
TABLE 2 General Characteristics of Studied Patients
Total
(n ¼ 363)
Both Abnormal
(A-Vessels)
Only FFR Abnormal
(B-Vessels)
Only Pd/Pa Abnormal
(C-Vessels)
Both Normal
(D-Vessels)
p ValuesPd/Pa #0.91, FFR #0.80 Pd/Pa >0.91, FFR #0.80 Pd/Pa #0.91, FFR >0.80 Pd/Pa >0.91, FFR >0.80
Age, yrs* 61.7 (59.5–63.9) 60.7 (58.6–62.8) 58.6 (55.8–61.4) 64.5 (60.7–68.2) 62.9 (60.9–64.8) <0.001
Male 75.6 (65.4–83.6) 80.0 (71.2–86.7) 72.4 (58.3–83.1) 62.9 (44.0–78.5) 75.1 (66.3–82.1) 0.130
Cardiovascular risk factors
Hypertension 49.3 (39.6–58.9) 45.8 (36.8–54.9) 41.2 (29.6–54.0) 71.4 (55.4–83.7) 50.7 (42.1–59.1) <0.001
Diabetes 20.2 (12.9–29.9) 18.1 (11.8–26.6) 29.3 (18.6–42.5)† 31.4 (17.6–49.7) 17.4 (11.4–25.6)‡ 0.002
Dyslipidemia 61.4 (50.8–71.0) 65.1 (55.4–73.6) 58.6 (44.8–71.2) 51.4 (34.0–68.5) 60.9 (51.7–69.3) 0.487
Smoker 29.0 (20.5–39.4) 30.7 (22.4–40.4) 37.9 (25.8–51.8) 17.1 (7.6–34.2) 27.1 (19.7–35.9) 0.279
Previous myocardial infarction 43.0 (33.3–53.5) 41.6 (32.5–51.1) 29.3 (18.6–42.7) 37.1 (22.3–54.9) 49.1 (40.0–58.1) 0.016
Multivessel disease 68.7 (58.5–77.2) 65.1 (55.6–73.4) 71.1 (57.8–81.7) 77.1 (59.6–88.5) 69.6 (60.8–77.1) 0.537
Unadjusted patient§ 291 (100) 102 (35.1) 42 (14.4) 24 (8.2) 123 (42.3) <0.001
*All analyses are adjusted means (95% CI) and adjusted prevalences (95% CI) with the exception of the unadjusted patient prevalence, which are n (%). †p <0.05 compared with D-vessels. ‡p <0.05
compared with B-vessels. §Patients with >1 interrogated vessels were excluded.
Abbreviations as in Table 1.
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(1,7).
STATISTICAL ANALYSIS. Data was analyzed on
per-patient basis for clinical characteristics and on per-
vessel basis for the rest of calculations. For patient-
level analyses, “center” was added as covariate to
linear and logistic regression models in order to
account for potential differences between the pop-
ulations. Huber-White robust standard errors were
used to adjust for additional variability of arteries from
the same subject. From these models, adjusted means
and prevalences with 95% conﬁdence intervals (CI) are
presented. For vessel-level analyses, we believed it
was better to document the consistencies and the dif-
ferences between the centers and their techniques to
measure ﬂow. Therefore, individual Doppler and
Thermo ﬁndings are also provided in the tables and in
the Online Appendix. Finally, because Pd/Pa, FFR, and
CFR are vessel-speciﬁc indices that link upstream
epicardial diseasewith the functionality and extension
of the downstream microcirculatory bed, indepen-
dence was assumed for vessel-level analyses. Contin-
uous variables are presented as mean  SD or median
(quartiles 1 and 3, Q1-3) and categorical variables as
counts and percentages. Normality and homogeneity
of the variances were tested using Shapiro-Wilk and
Levene tests, respectively. Continuous variables were
compared with Student t or Mann-Whitney U tests,
and categorical variables with chi-square or Fisher
exact tests, as appropriate. Correlation coefﬁcients
(Pearson r, Spearman r) between physiology indices
were calculated. For Pd/Pa dichotomization, receiver-
operating characteristic analyses were used to deter-
mine its optimal cutoff against FFR #0.80, deﬁned
as that maximizing correct classiﬁcation. Overalldifferences across Pd/Pa and FFR categories were
compared with 1-way analysis of variance, Kruskal-
Wallis, chi-square or Fisher exact tests, followed by
post-hoc Student t tests, or Mann-Whitney U or Fisher
exact tests with Bonferroni-adjusted signiﬁcance
level. In scatterplots, spherical controlled noise
(“jitter”) was used to prevent overprinting of dots.
Differences were considered signiﬁcant at p < 0.05 (2-
sided), and the STATA (version 12.1, StataCorp, College
Station, Texas) software was used for all calculations.
RESULTS
BASELINE CHARACTERISTICS. Clinical, angiogra-
phic, and physiological characteristics of the study
population are shown in Tables 2 and 3. In total, 467
stenosed vessels from 363 patients were investigated:
168 vessels (n ¼ 135) with thermodilution-derived
ﬂow (Thermo) and 299 vessels (n ¼ 228) with
Doppler-derived ﬂow (Doppler). Mean age was 62  11
years and the majority of patients (n ¼ 305, 84.0%)
underwent catheterization because of stable symp-
toms. Overall, coronary stenoses were of intermedi-
ate severity, both angiographically (diameter
stenosis: 52.7  11.4%) and physiologically (median
FFR ¼ 0.81 [Q1-3: 0.72, 0.88]).
RELATIONSHIP BETWEEN Pd/Pa AND FFR.
Figure 1 shows the scatterplot of the Pd/Pa and
FFR relationship. A moderate-to-strong correlation
between Pd/Pa and FFR was observed in the overall
population (r ¼ 0.798; 95% CI: 0.767 to 0.828), which
was similar between technologies (Online Figure 1):
Thermo-vessels: r ¼ 0.789 (95% CI: 0.724 to 0.839);
Doppler-vessels: r ¼ 0.821 (95% CI: 0.781 to 0.855);
p for r comparison ¼ 0.337. Using FFR #0.80 to deﬁne
TABLE 3 General Characteristics of Studied Vessels
Total
(n ¼ 467)
Both Abnormal
(A-Vessels)
Only FFR Abnormal
(B-Vessels)
Only Pd/Pa Abnormal
(C-Vessels)
Both Normal
(D-Vessels)
p Value
Pd/Pa #0.91, FFR #0.80
(n ¼ 166)
Pd/Pa >0.91, FFR #0.80
(n ¼ 59)
Pd/Pa #0.91, FFR >0.80
(n ¼ 35)
Pd/Pa >0.91, FFR >0.80
(n ¼ 207)
Stenosis location 0.008
LAD 226 (48.4) 98 (59.0) 32 (54.2) 16 (41.9) 80 (38.7)
LCX 110 (23.6) 28 (16.9) 12 (20.3) 8 (22.9) 62 (30.0)
RCA 131 (28.1) 40 (24.1) 15 (25.4) 11 (31.4) 65 (31.4)
Quantitative coronary angiography
RD, mm 2.84 (2.41, 3.29) 2.84 (2.38, 3.33) 2.72 (2.35, 3.26) 2.68 (2.29, 3.05) 2.90 (2.50, 3.37) 0.231
MLD, mm 1.24 (1.03, 1.59) 1.11 (0.88, 1.33)* 1.19 (1.03, 1.56)* 1.26 (1.07, 1.54) 1.44 (1.14, 1.71)†‡ <0.001
DS, % 53  11 58  12*§ 54  10* 49  9† 49  10†‡ <0.001
Physiology parameters
Pd/Pa 0.93 (0.88, 0.96) 0.85 (0.70, 0.89) 0.94 (0.93, 0.96) 0.90 (0.89, 0.91) 0.96 (0.94, 0.98) —
FFR 0.81 (0.72, 0.88) 0.69 (0.55, 0.75) 0.76 (0.73, 0.79) 0.85 (0.82, 0.87) 0.89 (0.86, 0.93) —
Pd/Pa- FFR 0.10 (0.06, 0.16) 0.13 (0.09, 0.19)*†‡ 0.19 (0.16, 0.22)*†§ 0.05 (0.03, 0.07)*†‡ 0.07 (0.04, 0.10)†‡§ <0.001
Measurements of ﬂow
CFR, allk 2.16 (1.54, 2.70) 1.60 (1.27, 2.20)*‡§ 2.40 (1.89, 2.91)†§ 2.01 (1.44, 2.50)*†‡ 2.43 (1.95, 3.00)†§ <0.001
CFVR, Doppler 2.21 (1.70, 2.76) 1.60 (1.30, 2.17)*§ 2.40 (1.92, 2.91)§ 2.17 (1.88, 2.84)† 2.50 (2.15, 3.00)† <0.001
CFR, Thermo 1.90 (1.39, 2.7) 1.60 (1.10, 2.35)* 2.22 (1.50, 3.1) 1.81 (1.40, 2.42) 2.18 (1.51, 3.09)† 0.019
APV, baseline 16 (12, 21) 14 (10, 20) 17 (12, 23) 16 (15, 23) 17 (13, 20) 0.059
APV, hyperemia 36 (26, 49) 26 (16, 39)*‡§ 38 (30, 51)† 45 (30, 54)† 41 (32, 54)† <0.001
Tmn, baseline 0.59 (0.33, 0.91) 0.56 (0.30, 0.84) 0.72 (0.48, 1.33) 0.50 (0.33, 0.73) 0.71 (0.38, 1.17) 0.181
Tmn, hyperemia 0.29 (0.20, 0.44) 0.30 (0.22, 0.42) 0.32 (0.22, 0.51) 0.25 (0.17, 0.33) 0.31 (0.19, 0.44) 0.577
Measurements of SR
BSR, Doppler 0.40 (0.17, 0.82) 1.06 (0.74, 2.55)*†‡ 0.33 (0.20, 0.47)*†§ 0.57 (0.45, 0.71)*†‡ 0.17 (0.11, 0.30)†‡§ <0.001
HSR, Doppler 0.50 (0.26, 0.87) 1.13 (0.76, 2.86)*‡§ 0.61 (0.38, 0.79)*†§ 0.32 (0.48, 0.65)*†‡ 0.25 (0.14, 0.36)†‡§ <0.001
BSR, Thermo 3.60 (1.77, 6.84) 6.72 (3.91, 12.15)*‡§ 3.36 (0.87, 9.31)*† 4.59 (3.3, 5.8)*† 1.79 (0.98, 3.52)†‡§ <0.001
HSR, Thermo 3.71 (2.10, 5.97) 5.94 (3.90, 8.99)*§ 4.59 (3.36, 8.40)*§ 2.82 (2.10, 3.90)†‡ 2.34 (2.10, 5.97)†‡ <0.001
Measurements of MR
BMR, Doppler 5.44 (4.15, 7.08) 5.13 (3.81, 7.00)* 5.54 (4.04, 708) 5.00 (4.13, 6.07) 5.80 (4.90, 7.38)† 0.041
HMR, Doppler 2.07 (1.56, 2.75) 2.20 (1.58, 2.95) 1.87 (1.32, 2.37) 1.91 (1.50, 2.30) 2.08 (1.61, 2.67) 0.058
BMR, Thermo 45.4 (26.5, 77.3) 32.8 (21.7, 71.2)* 51.1 (41.0, 123.7) 35.9 (30.7, 48.4)* 55.2 (34.5, 92.7)†§ 0.005
HMR, Thermo 17.5 (12.2, 25.9) 16.2 (10.3, 21.6) 12.1 (11.3, 23.2) 17.09 (10.5, 22.4) 19.4 (14.4, 30.1) 0.039
Values are n (%), median (quartile 1, quartile 3), or mean  SD. *p <0.05 compared with D-vessels. †p <0.05 compared with A-vessels. ‡p <0.05 compared with B-vessels. §p <0.05
compared with C-vessels. kDoppler and thermodilution vessels.
APV ¼ average peak ﬂow velocity; BMR ¼ baseline microcirculatory resistance; BSR ¼ baseline stenosis resistance; CFVR ¼ coronary ﬂow velocity reserve; DS ¼ diameter stenosis; HMR ¼
hyperemic microcirculatory resistance; HSR ¼ hyperemic stenosis resistance; LAD ¼ left anterior descending artery; LCX ¼ left circumﬂex artery; MLD ¼minimum lumen diameter; RCA ¼ right
coronary artery; RD ¼ reference diameter; Thermo ¼ thermodilution; Tmn ¼ mean transit time; other abbreviations as in Table 1.
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analyses identiﬁed 0.91 as the optimal Pd/Pa cutoff,
with an area under the curve of 0.882 (95% CI: 0.851
to 0.913) (Figure 1B). This 0.91 Pd/Pa cutoff classiﬁed
correctly 80.7% of total stenoses, with a sensitivity of
68.9% and speciﬁcity of 91.7%. Consequently,
Pd/Pa #0.91 (n ¼ 201 [43.0%]) and FFR #0.80 (n ¼ 225
[48.2%]) were used for further categorizations:
A-vessels: both Pd/Pa and FFR are abnormal
(Pd/Pa #0.91 and FFR #0.80, n ¼ 166 [35.6%]);
B-vessels: only FFR is abnormal (Pd/Pa >0.91 and
FFR #0.80, n ¼ 59 [12.6%]); C-vessels: only Pd/Pa is
abnormal (Pd/Pa #0.91 and FFR >0.80, n ¼ 35 [7.5%]);
and D-vessels: both Pd/Pa and FFR are normal
(Pd/Pa >0.91 and FFR >0.80, n ¼ 207 [44.3%]);
B-vessels and C-vessels are discordant-vessels.Finally and with the aim to explore a perfect
classiﬁcation agreement between Pd/Pa and FFR on
individual basis, no Pd/Pa cutoff was able to exclude
the development of an FFR #0.80 in the high end
of values, whereas, conversely, all stenosis with
Pd/Pa #0.83 (n ¼ 74, 15.8%) developed FFR #0.80.
CLINICAL CHARACTERISTICS ACROSS THE Pd/Pa
AND FFR CATEGORIES. Table 2 depicts the clinical
characteristics of the study population. Some were
different across the Pd/Pa and FFR categories.
The more signiﬁcant differences were age and the
prevalence of hypertension: B-vessels were more
frequently observed in younger patients, whereas
C-vessels were more prevalent in elderly and hyper-
tensive patients.
FIGURE 1 Baseline Pd/Pa and FFR Relationship
(A) Scatterplot of the baseline distal-to-aortic pressure ratio (Pd/Pa) and fractional ﬂow reserve (FFR) relationship. The horizontal and vertical
lines are placed at the Pd/Pa (0.91) and FFR (0.80) cutoffs, respectively. (B) Receiver-operating characteristic (ROC) curve of Pd/Pa against
FFR #0.80.
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1685RELATIONSHIP OF Pd/Pa AND FFR WITH
MEASUREMENTS OF FLOW. Pd/Pa (r ¼ 0.474; 95%
CI: 0.401 to 0.542, p < 0.001) and FFR (r ¼ 0.344; 95%
CI: 0.261 to 0.442, p < 0.001) were both signiﬁcantly
correlated with CFR (Figure 2), although Pd/Pa
correlated more strongly (r difference ¼ 0.129; 95%
CI: 0.066 to 0.243, p for r comparison < 0.001).
Overall, coronary ﬂow increased with hyperemia a
median of þ116% (Q1-3: þ54%, þ172%). However, the
increase in ﬂow (Tables 3 and 4, Figure 3) was
signiﬁcantly different across Pd/Pa and FFR cate-
gories (p for overall comparison <0.001). The smallest
and largest increases in ﬂow were observed in
A-vessels (median: þ60% [Q1-3: þ25%, þ120%]) and
D-vessels (median: þ140% [Q1-3: þ91%, þ192%]),
respectively. C-vessels exhibited moderate increases
of ﬂow (median: þ97% [Q1-3: þ45%, þ154%]), whe-
reas, notably, the increase in ﬂow of B-vessels was
high (median: þ144% [Q1-3: þ95%, þ201%]) and did
not statistically differ (p ¼ 0.977) from that observed
in the most normal D-vessels. Similar trends were
observed when the percentage of vessels with
exhausted ﬂow reserve (CFR <2) was investigated
across Pd/Pa and FFR categories (Figure 2B). If base-
line Pd/Pa was >0.91 (n ¼ 266, 57%), the prevalence of
exhausted CFR was low (n ¼ 82, 30.8%), and did not
statistically differ (p ¼ 0.425) whether ﬁnal FFR
was #0.80 (B-vessels: n ¼ 32, 35.6%) or >0.80
(D-vessels: n ¼ 61, 29.5%). Conversely, if Pd/Pa was
#0.91 (n ¼ 201, 43%), the prevalence of exhausted
CFR was high (n ¼ 201, 63.7%), and only marginallystatistically different (p ¼ 0.053) whether ﬁnal FFR
was #0.80 (A-vessels: n ¼ 111, 66.9%) or >0.80
(C-vessels: n ¼ 17, 48.6%).
STENOSIS RESISTANCE ACROSS Pd/Pa AND FFR
CATEGORIES. Baseline and hyperemic SR values
were signiﬁcantly different across the Pd/Pa and FFR
categories (Table 2). The highest SR were observed in
A-vessels, the lowest in D-vessels, and discordant-
vessels exhibited intermediate SR values. Hyperemia
increased SR a median of þ11% (Q1-3: -21%, þ62%) in
the total vessel population. However, the modiﬁca-
tion in SR induced by hyperemia was very different
across Pd/Pa and FFR categories. As shown in Table 3
and Figure 3, in concordantly abnormal and normal
vessels, SR was only slightly modiﬁed by hyperemia,
as it only increased a median of þ6% (Q1-3:
-15%, þ23%) in A-vessels and þ17% (Q1-3: -22%, þ79%)
in D-vessels. In discordant-vessels, however, the
modiﬁcation in SR with hyperemia was more sub-
stantial, as it increased a median of þ72% (Q1-3:
þ25%, þ160%) in B-vessels, whereas it decreased a
median of -33% (Q1-3: -46%, -16%) in C-vessels. Con-
sistency in this ﬁnding was observed in both Thermo-
vessels and Doppler-vessels (Table 4, Figure 3).
MICROCIRCULATORY RESISTANCE ACROSS Pd/Pa
AND FFR CATEGORIES. In the total population,
hyperemia decreased MR a median of -61% (Q1-3:
-70%, -50%) (Table 3). The reduction in MR was
largest in B-vessels (median: -68% [Q1-3: -77%, -59%])
and smallest in A-vessels (median: -54% [Q1-3: -65%,
FIGURE 2 Relationship of CFR With Baseline Pd/Pa and FFR
(A) Scatterplot showing the Pd/Pa relationship with coronary ﬂow reserve (CFR). (B) The proportion of vessels with exhausted ﬂow reserve
(CFR <2) across Pd/Pa and FFR categories is shown. (C) Scatterplot showing the FFR relationship with CFR. In the scatterplots, the vertical lines
are placed at Pd/Pa (0.91) and FFR (0.80) cutoffs, respectively, and horizontal lines at the CFR (2) cutoff. Abbreviations as in Figure 1.
TABLE 4 Change in Flow, SR, and MR Measurements Across Pd/Pa and FFR Categories
Total
(n ¼ 467)
Both Abnormal
(A-Vessels)
Only FFR Abnormal
(B-Vessels)
Only Pd/Pa Abnormal
(C-Vessels)
Both Normal
(D-Vessels)
p Value
Pd/Pa #0.91, FFR #0.80
(n ¼ 166)
Pd/Pa >0.91, FFR #0.80
(n ¼ 59)
Pd/Pa #0.91, FFR >0.80
(n ¼ 35)
Pd/Pa >0.91, FFR >0.80
(n ¼ 207)
Change in ﬂow, %
Overall 116 (54, 172) 60 (25, 120)*†‡ 140 (91, 192)†§ 97 (45, 154)*‡§ 144 (95, 201)†§ <0.001
Doppler-vessels 122 (68, 176) 59 (30, 114)*†‡ 143 (97, 192)§ 117 (88, 184)§ 150 (115, 200)§ <0.001
Thermo-vessels 88 (39, 167) 61 (12, 135) 121 (49, 213) 81 (43, 141) 115 (51, 208) 0.018
Change in SR, %
Overall 11 (-21, 62) 6 (-15, 23)*†§ 72 (25, 160)†‡§ -33 (-46,-16)*‡§ 17 (-22, 79)*†§ <0.001
Doppler-vessels 16 (-15, 71) 11 (-9, 25)*† 73 (25, 150)†‡§ -33 (-45, -13)*‡§ 19 (-22, 83)*† <0.001
Thermo-vessels -3 (-31, 36) -9 (-26, 20)*†§ 51 (28, 200)†‡§ -36 (-46, -25)*‡§ 11 (-21, 67)*†§ <0.001
Change in MR, %
Overall -61 (-70, 50) -54 (-65, -38)*‡ -68 (-77, -59)†‡§ -54 (-70, -43)*‡ -64 (-71, -54)*†§ <0.001
Doppler-vessels -62 (-69, 52) -54 (-64, -41)*‡ -68 (-75, -59)†§ -55 (-70, -51)* -64 (-70, -58)§ <0.001
Thermo-vessels -59 (-72, -41) -55 (-71, -35) -69 (-77, -59) -53 (-69, -37) -62 (-73, -45) 0.166
Values are median (quartile 1, quartile 3) percentage of change from baseline to hyperemia. *p <0.05 compared with B-vessels. †p <0.05 compared with C-vessels. ‡p <0.05
compared with D-vessels. §p <0.05 compared with A-vessels.
Abbreviations as in Tables 1 and 3.
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FIGURE 3 Hyperemic Modiﬁcation in Flow, SR, and MR Across Pd/Pa and
FFR Categories
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1687-38%]) and C-vessels (median: -54% [Q1-3: -70%,
-43%]). In Doppler-vessels, the minimum MR was
not statistically different across the Pd/Pa and FFR
categories, whereas in Thermo-vessels, an overall
signiﬁcant difference was observed, being lower and
higher in B-vessels and D-vessels, respectively
(Table 2, Figure 3).Bar plots of median percentage of change from baseline to hyperemia, in ﬂow, stenosis
resistance (SR) and microcirculatory resistance (MR) across Pd/Pa and FFR categories.
Overall and individual thermodilution (Thermo) and Doppler ﬁndings are provided. Please
note that this plot shows median percentage of change, and not baseline nor hyperemic
values. Such values are provided in Table 3. Abbreviations as in Figure 1.DISCUSSION
Notwithstanding the limitations of considering a
“true“ baseline (8) and a “true“ maximal hyperemic
state (10), in this work we explored the possibility of
expanding with simplicity the physiological assess-
ment of coronary stenosis by combining Pd/Pa with
the standard FFR. This is important at a time when
randomized trials have moved optimal guidance of
coronary revascularization from angiography to
physiology (1) and emerging data supports the notion
that hyperemia-free indices can accurately determine
the ischemic potential of coronary stenosis in
selected subsets (2–4).
We observed that a baseline Pd/Pa value of 0.91
classiﬁed correctly the majority (80.7%) of the ste-
nosis against that clinically adopted 0.80 FFR cutoff.
Furthermore, we observed that Pd/Pa was more
closely correlated with CFR than FFR, and that the
Pd/Pa and FFR discordance was associated with the
patients’ clinical proﬁle and characterized by con-
trastive changes in SR, MR, and the underlying CFR.
The combination of baseline Pd/Pa with FFR seems
hence to provide a more comprehensive physiological
examination of stenosed coronary arteries and a
closer pressure-based appraisal of the ﬂow reserve of
the downstream myocardial bed.
COMBINING BASELINE Pd/Pa WITH FFR IN THE
ASSESSMENT OF CORONARY STENOSIS SEVERITY.
From a broad perspective, intracoronary physiology
has pursued standardized hyperemic stress to assess
coronary stenosis severity, largely neglecting the in-
formation readily available during the baseline state.
This rationale contrasts with that of all the other
noninvasive tests aimed to detect electrical, contrac-
tile, or perfusional manifestations of ischemia, in
which hyperemic ﬁndings are always weighted against
those observed during baseline. Nevertheless, inter-
ventionalists are accustomed to witness modiﬁcations
of variable magnitude in the Pd/Pa ratio, from the time
they cross the stenosis during baseline to the moment
of achievement of hyperemia. For example, an FFR
value of 0.70 may develop from a near-normal base-
line Pd/Pa of 0.99, or from a frankly abnormal Pd/Pa
of 0.80. This Pd/Pa value, however, is conventionallynot considered worthwhile—even though it is always
readily accessible—and therefore all stenoses reaching
the same FFR value are currently pondered alike. Our
ﬁndings suggest that the physiological assessment of
epicardial stenosis severity with the standard FFR is
augmented by the simple incorporation of the baseline
Pd/Pa, because the CFR underlying a low (#0.80) or a
high (>0.80) FFR value was largely dependent on the
initial Pd/Pa value (Figure 4). We documented that
most vessels with near-normal (>0.91) Pd/Pa values
exhibited concomitant nonischemic CFR values,
even if a ﬁnal FFR #0.80 was achieved (Figure 5A).
Conversely, a signiﬁcant percentage of vessels with
abnormal (#0.91) Pd/Pa exhibited moderately to
highly exhausted CFR values, even if a ﬁnal FFR>0.80
was only achieved (Figure 5A). Therefore, the combi-
nation of baseline Pd/Pa with FFR seems physiologi-
cally incremental and practically appealing. In the
same line, our ﬁndings substantiate the observed
better correlation of the underlying CFR with baseline
rather than hyperemic pressure-indices (11), which
provides further support to the clinical use of the
baseline state. Finally and comparable with previous
studies (3,4), we observed that Pd/Pa and FFR
dichotomously disagreed in approximately 20% of
vessels. In the following paragraphs, these hemody-
namic patterns are discussed in detail.
VESSELSWITH BASELINE Pd/Pa > 0.91 AND FFR £ 0.80.
Stenosed coronary arteries exhibiting mild pressure
FIGURE 4 Schematic Representation of Hemodynamic Patterns Derived From the Pd/Pa and FFR Relationship
This ﬁgure summarizes the observed values of SR, the increase in ﬂow, and the drop in MR during baseline and hyperemia across the Pd/Pa and
FFR categories. (A) Vessels with Pd/Pa #0.91 and FFR <0.80 (A-vessels) are shown. The increase in ﬂow was lowest, SR highest, and the drop
in MR relatively low. SR was only slightly modiﬁed by hyperemia. (B) Vessels with Pd/Pa >0.91 and FFR >0.80 (D-vessels) are shown. Herein,
the rise in ﬂow was highest, SR lowest, and the drop in MR high. SR was only slightly modiﬁed by hyperemia. (C) Vessels with Pd/Pa >0.91 and
FFR #0.80 (B-vessels) are shown. Here, the increase in ﬂow was very high, SR low, and the drop in MR the highest. SR was signiﬁcantly
modiﬁed, increasing from low to intermediate values. Finally, (D) vessels with Pd/Pa #0.91 and FFR >0.80 (C-vessels) are shown. Herein, the
increase in ﬂow was only moderate, SR was intermediate at baseline, and the decrease in MR was low. SR was signiﬁcantly modiﬁed, decreasing
from intermediate to low hyperemic values. Abbreviations as in Figures 1 and 3.
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1688drops at baseline (Pd/Pa >0.91) that signiﬁcantly
worsened (FFR#0.80) during hyperemia represented
12.6% of the total population and most (62.8%) of the
Pd/Pa and FFR disagreement. Physiologically, this
pattern was characterized by low baseline SR that
signiﬁcantly increased during hyperemia (þ73%),
achieving ﬁnal intermediate magnitudes, large in-
creases in ﬂow (þ140%), and the largest drops (-68%)
in MR. Because pressure loss due to friction pre-
dominates during baseline and pressure loss due to
separation predominates during hyperemia (12), it
seems reasonable to speculate that in this type of
vessels, friction energy losses are small whereas
separation energy losses are more substantial.
Although the mechanisms leading to the observed
large hyperemic rise in SR in this vessels’ subgroup
are unclear, it seems plausible to suggest that these
stenoses are prone to separation losses, either due totheir ﬁxed anatomical components or to hyperemic
changes in their functional geometry (13), such as the
partial collapsing as described by Brown et al. (13) and
Siebes et al. (14) (“dynamic stenosis“) or hyperemic
vasodilation at the exit throat (“D” losses) as pro-
posed by Gould (12). Importantly and in spite of
achieving ﬁnal FFR values #0.80, the increase in ﬂow
in these vessels was high and did not statistically
differ from that observed in the most normal (Pd/Pa
>0.91 and FFR >0.80) D-vessels. This could be
explained by the fact that SR only reached interme-
diate levels at hyperemia. Finally, the sizable drop in
MR possibly indicates preserved autoregulation and
microcirculatory function. Altogether, these ﬁndings
help to justify why these hemodynamic patterns were
more likely observed in younger subjects and in pa-
tients where hypertension was less likely, because
hypertension (15) and increasing age (16) have been
FIGURE 5 Relationship of CFR With Baseline Pd/Pa and FFR
These plots link individual Pd/Pa and FFR values with their underlying CFR. (A) This panel is a summary. Solid lines were ﬁtted using a linear þ
quadratic ﬁt through the median values of Pd/Pa and the median values of FFR observed in each category. Distance in x-axis is median CFR of
each category. All dashed lines represent interquartile ranges. (B) All vessels are shown. Colors are those of the Pd/Pa and FFR categories
shown in the legend. Please note this is only a schematic representation, as the transition from Pd/Pa to FFR is not linear. Abbreviations as in
Figures 1 and 2.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 3 , 2 0 1 5 Echavarría-Pinto et al.
N O V E M B E R 2 0 1 5 : 1 6 8 1 – 9 1 Combining Baseline Pd/Pa With FFR
1689associated with a decrease in the hyperemic response.
From a clinical point of view, our data suggest that
the underlying CFR of most vessels with FFR #0.80
values arising from near-normal Pd/Pa values will not
be exhausted by the stenosis. Figure 6 shows in-depth
analyses of this assumption, where B-vessels (Pd/Pa
>0.91 and FFR #0.80) were further examined ac-
cording to more clinically meaningful CFR ischemic
thresholds (1,17,18). Notably the same ﬁgure illus-
trates how among all vessels with Pd/Pa $0.96
(n ¼ 149, 31.9%), only 15 (10.1%) developed FFR #0.80
(Figure 6), from which none had deﬁnite ischemia, as
deﬁned by CFR #1.74, and only 5 (3.4%) had mild to
moderate ischemia, as deﬁned by CFR >1.74 to <2.0
(1,17,18). Because substantial data support the notion
that the risk of future adverse events is low when the
CFR is preserved (1,17,18), it seems reasonable to
question whether the small proportion of FFR #0.80
vessels arising from Pd/Pa values $0.96 will receive
signiﬁcant beneﬁt from revascularization.
VESSELS WITH BASELINE Pd/Pa £0.91 AND
FFR >0.80. Vessels exhibiting fairly important pres-
sure drops at baseline (Pd/Pa #0.91) that did not
signiﬁcantly worsened during hyperemia (FFR >0.80)
were the scarcest (7.5%). Herein, the increase in ﬂow
was moderate (þ97%), and the drop (-54%) in MR waslow. Because most of the energy loss during baseline
is explained by viscous friction (12), it can be hy-
pothesized that in these vessels, the fairly important
pressure loss at baseline and the absence of a signiﬁ-
cant worsening (FFR #0.80) during hyperemia could
suggest meaningful friction but small separation en-
ergy losses, ﬁndings compatible with predominant
diffuse atherosclerosis (1,12). The concomitantly small
drop in MR could alternatively suggest microcircula-
tory dysfunction as the cause of the moderately
exhausted CFR (19). Interestingly, in this hemody-
namic pattern, SR was intermediate at baseline and
was signiﬁcantly reduced (-33%) to low levels in hy-
peremia. The reduction in SR from baseline to hy-
peremia is a poorly described phenomenon, suggested
by Brown et al. (13) and appraised invasively in
humans by Sambuceti et al. (20). Although the
mechanisms underlying this hyperemic decrease in
SR are unclear, it seems plausible to suggest that
diffuse atherosclerosis or less likely paradoxical
hyperemic epicardial vasoconstriction (by modifying
the functional geometry of the stenosis and
decreasing separation losses at the exit throat) could
lead to this condition (21,22). Finally, almost one-half
of these vessels (48.6%) presented an exhausted CFR.
Because a diminished CFR conveys a signiﬁcant risk
for future adverse events (1,18), it seems reasonable to
PERSPECTIVES
WHAT IS KNOWN? Baseline Pd/Pa is always
accessible before FFR assessment, and emerging data
support the notion that baseline indices can determine
the ischemic potential of coronary stenosis in selected
subsets.
WHAT IS NEW? Discordance between baseline
Pd/Pa and FFR is associated with the patients’ clinical
proﬁle and is characterized by contrastive changes in
SR, MR, and CFR. CFR underlying a low or a high FFR
is largely dependent on the initial Pd/Pa value.
Combining baseline Pd/Pa with FFR seems to provide
a more comprehensive physiological examination of
stenosed coronary arteries.
WHAT IS NEXT? Future studies should focus now on
the possible role of baseline physiology indices in the
clinical decision-making process.
FIGURE 6 Hypothetical Consequences of a Pd/Pa $0.96 Deferral Strategy
B-vessels (stenosis with Pd/Pa >0.91 and FFR #0.80) are shown across more meaningful
ranges of CFR impairment. Among all stenoses with Pd/Pa >0.91 that are candidates for
revascularization according to FFR #0.80, no stenosis with Pd/Pa $0.96 (highlighted in
red and above the horizontal dotted line) had CFR #1.74, which is highly suggestive of
deﬁnite ischemia. Moreover, only 5 (3.4%) of the stenoses with FFR #0.80 parting from
Pd/Pa $0.96 had a CFR suggestive of mild to moderate ischemia (>1.74 and CFR <2.0).
These high Pd/Pa values were not anecdotal, because across the whole study population
(n ¼ 467), a signiﬁcant proportion of vessels (n ¼ 149, 31.9%) had Pd/Pa $0.96.
Abbreviations as in Figures 1 and 2.
Echavarría-Pinto et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 3 , 2 0 1 5
Combining Baseline Pd/Pa With FFR N O V E M B E R 2 0 1 5 : 1 6 8 1 – 9 1
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a worse prognosis in spite of an FFR value above 0.80.
STUDY LIMITATIONS. First, Pd/Pa and FFR were used
in a dichotomous fashion. Whereas this approach
oversimpliﬁes the continuum of risk, it also increases
clinical applicability, and is currently advocated for
FFR use. Second, different hyperemic routes and
doses of adenosine were used, as well as methodol-
ogies to measure intracoronary ﬂow. However, con-
sistency in individual ﬁndings was noted between
Doppler-vessels and Thermo-vessels, which we
believe strengthens the external validity and impli-
cations of our observations. Third, investigated ste-
noses were of intermediate angiographic severity, so
the generalization of our ﬁndings to other ranges of
disease is unclear. Fourth and most importantly,
clinical inference remains speculative, particularly in
the light of the well-documented clinical beneﬁt of
FFR guidance of coronary revascularization as
compared with that of angiography. Finally and even
if initial invasive data is encouraging (7), it should
be acknowledged that most of CFR prognostic in-
formation comes from noninvasive studies (1,18).
Hence, caution should be urged when translating thepowerful risk stratiﬁcation of CFR to the inva-
sive sphere. The DEFINE-FLOW (Combined Pressure
and Flow Measurements to Guide Treatment of
Coronary Stenoses) study (NCT02328820) is currently
evaluating the safety of PCI deferral in vessels with
low FFR but preserved CFR and will shed further
lights on the topic.
CONCLUSIONS
In this workwe sought to understand the physiological
basis of baseline Pd/Pa and FFR agreement and
discordance with combined pressure and ﬂow mea-
surements. Although Pd/Pa and FFR were closely
correlated, discordance was observed in 19.3% of ves-
sels. Such discordance was associated with the pa-
tient’s clinical proﬁle and characterized by contrastive
changes in SR, MR, and the underlying CFR. All ste-
nosis with Pd/Pa #0.83 (n ¼ 74, 15.8%) progressed to
FFR #0.80, and although no Pd/Pa cutoff was able to
exclude the development of an FFR #0.80 in the high
end of values, only 15 vessels (10.1%) with Pd/Pa$0.96
(n ¼ 149, 31.9%) developed FFR #0.80, from which
none had deﬁnite ischemia, as deﬁned by CFR #1.74.
Combining baseline Pd/Pa with FFR seems thus to
provide a more comprehensive physiological exami-
nation of stenosed coronary arteries.
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